D. E. Shaw Research, LLC

Also on record

Records under this name other than the patents D. E. Shaw Research, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.

Back to D. E. Shaw Research, LLC

Patent	Title	Status	Expires	Confidence
US 9,612,832	Parallel Processing System for Computing Particle Interactions now held by David E. Shaw In force Term ends Aug 28, 2027 · High confidence	In force	Term ends Aug 28, 2027	High confidence
US 9,906,467	Inverse Weighted Arbitration now held by D.E. Shaw In force Term ends Jul 23, 2035 · High confidence	In force	Term ends Jul 23, 2035	High confidence
US 11,529,347	SHP2 Phosphatase Inhibitors and Methods of Use Thereof now held by Relay Therapeutics, Inc. In force Term ends Sep 22, 2037 · High confidence	In force	Term ends Sep 22, 2037	High confidence
US 11,629,145	SHP2 Phosphatase Inhibitors and Methods of Use Thereof now held by Relay Therapeutics, Inc. In force Term ends Oct 24, 2037 · High confidence	In force	Term ends Oct 24, 2037	High confidence
US 11,591,336	SUBSTITUTED PYRAZOLO[3,4-b]PYRAZINES AS SHP2 PHOSPHATASE INHIBITORS now held by Relay Therapeutics, Inc. In force Term ends May 25, 2038 · High confidence	In force	Term ends May 25, 2038	High confidence
US 11,701,354	Pyrazolo[3,4-b]pyrazine Derivatives as SHP2 Phosphatase Inhibitors now held by Relay Therapeutics, Inc. In force Term ends Sep 28, 2038 · High confidence	In force	Term ends Sep 28, 2038	High confidence
US 12,331,056	SHP2 Phosphatase Inhibitors and Methods of Use Thereof now held by Relay Therapeutics, Inc. In force Term ends Mar 21, 2039 · Medium confidence	In force	Term ends Mar 21, 2039	Medium confidence
US 12,084,447	SHP2 Phosphatase Inhibitors and Methods of Use Thereof now held by Relay Therapeutics, Inc. In force Ends no later than Feb 21, 2040 · Medium confidence	In force	Ends no later than Feb 21, 2040	Medium confidence
US 11,780,845	FGFR Inhibitors and Methods of Use Thereof now held by Relay Therapeutics, Inc. In force Term ends May 12, 2040 · High confidence	In force	Term ends May 12, 2040	High confidence
US 12,581,252	SUBSTITUTED PYRROLO[3,4-b]PYRIDINES AS PI3K-ALPHA INHIBITORS now held by Relay Therapeutics, Inc. In force Term ends Jul 17, 2041 · High confidence	In force	Term ends Jul 17, 2041	High confidence

10 of 46 records shown.

Pro members see all 46.

Pro members: see all 46 records